Characteristics of Surgical Prosthetic Heart Valves and Problems Around Labeling: A Document From the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) Valve Labelling Task Force

J Thorac Cardiovasc Surg. 2019 Oct;158(4):1041-1054. doi: 10.1016/j.jtcvs.2019.04.001. Epub 2019 May 10.


Intraoperative surgical prosthetic heart valve (SHV) choice is a key determinant of successful surgery and positive postoperative outcomes. Currently, many controversies exist around the sizing and labeling of SHVs rendering the comparison of different valves difficult. To explore solutions, an expert Valve Labelling Task Force was jointly initiated by the European Association for Cardio-Thoracic Surgery (EACTS), The Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS). The EACTS-STS-AATS Valve Labelling Task Force, comprising cardiac surgeons, cardiologists, engineers, regulators and representatives from the International Organization for Standardization (ISO), and major valve manufacturers, held its first in-person meeting in February 2018 in Paris, France. This article was derived from the meeting's discussions. The Task Force identified the following areas for improvement and clarification: reporting of physical dimensions and characteristics of SHVs determining and labeling of SHV size, in vivo and in vitro testing, and reporting of SHV hemodynamic performance and thrombogenicity. Furthermore, a thorough understanding of the regulatory background and the role of the applicable ISO standards, together with close cooperation between all stakeholders (including regulatory and standard- setting bodies), is necessary to improve the current situation. Cardiac surgeons should be provided with appropriate information to allow for optimal SHV choice. This first article from the EACTS-STS-AATS Valve Labelling Task Force summarizes the background of SHV sizing and labeling and identifies the most important elements where further standardization is necessary.

Keywords: International standard; aortic valve replacement; device approval; labeling; lnternational Organization for Standardization (ISO); mitral valve replacement; objective performance criteria (OPC); prosthesis–patient mismatch (PPM); prosthetic heart valve; regulation; sizing; surgical prosthetic heart valve (SHV); valve performance.

Publication types

  • Consensus Development Conference
  • Practice Guideline
  • Review

MeSH terms

  • Bioprosthesis / standards*
  • Cardiology / standards*
  • Clinical Decision-Making
  • Consensus
  • Consumer Product Safety / standards*
  • Equipment Failure Analysis / standards
  • Heart Valve Prosthesis / standards*
  • Heart Valve Prosthesis Implantation / adverse effects
  • Heart Valve Prosthesis Implantation / instrumentation*
  • Heart Valve Prosthesis Implantation / standards*
  • Humans
  • Patient Selection
  • Product Labeling / standards*
  • Prosthesis Design / standards*
  • Prosthesis Failure
  • Societies, Medical